methotrexate ( mtx ) , administered as a single 20 mg/kg intraperitoneal dose to c57bl/6j mice on their 9th day of pregnancy results in high incidences of median facial clefts in the surviving gestational-day-18 fetuses .
C0025677
methotrexate
C0032961
pregnancy